Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Other Working Capital Changes (2020 - 2025)

Historic Other Working Capital Changes for Arcutis Biotherapeutics (ARQT) over the last 6 years, with Q3 2025 value amounting to $1.8 million.

  • Arcutis Biotherapeutics' Other Working Capital Changes fell 5859.8% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $808000.0, marking a year-over-year increase of 23835.62%. This contributed to the annual value of $948000.0 for FY2024, which is 8900.36% down from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Other Working Capital Changes stood at $1.8 million for Q3 2025, which was down 5859.8% from -$4.3 million recorded in Q2 2025.
  • In the past 5 years, Arcutis Biotherapeutics' Other Working Capital Changes registered a high of $12.7 million during Q1 2021, and its lowest value of -$5.5 million during Q1 2024.
  • In the last 5 years, Arcutis Biotherapeutics' Other Working Capital Changes had a median value of -$87000.0 in 2022 and averaged $745684.2.
  • Per our database at Business Quant, Arcutis Biotherapeutics' Other Working Capital Changes crashed by 131923.08% in 2021 and then skyrocketed by 368041.67% in 2023.
  • Quarter analysis of 5 years shows Arcutis Biotherapeutics' Other Working Capital Changes stood at $1.2 million in 2021, then plummeted by 196.62% to -$1.2 million in 2022, then decreased by 24.98% to -$1.5 million in 2023, then skyrocketed by 104.5% to $66000.0 in 2024, then skyrocketed by 2566.67% to $1.8 million in 2025.
  • Its Other Working Capital Changes was $1.8 million in Q3 2025, compared to -$4.3 million in Q2 2025 and $3.3 million in Q1 2025.